News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LESCHLY MARK
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2022 |
4
| LESCHLY MARK (Director) has filed a Form 4 on ChargePoint Holdings, Inc.|
Txns:
| Granted 13,563 shares
@ $0 |
|
| 07/14/2021 |
4
| LESCHLY MARK (Director) has filed a Form 4 on ChargePoint Holdings, Inc.|
Txns:
| Granted 3,192 shares
@ $0 |
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/22/2020 |
4
| LESCHLY MARK (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 16,806 options to buy
@ $20.37, valued at
$342.3k
|
|
| 05/17/2019 |
4
| LESCHLY MARK (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 24,000 options to buy
@ $13.35, valued at
$320.4k
|
|
| 04/10/2019 |
4
| LESCHLY MARK (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Converted 3,766,667 shares
@ $0
Converted 3,000,000 preferred shares
@ $0
Converted 600,000 preferred shares
@ $0
Converted 166,667 preferred shares
@ $0 |
|
| 04/03/2019 |
3
| LESCHLY MARK (Director) has filed a Form 3 on NGM BIOPHARMACEUTICALS INC |
| 04/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/18/2016 |
4
| RHO Ventures VI LP (10% Owner) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Bought 152,273 shares
@ $4.7798, valued at
$727.8k
Bought 247,727 shares
@ $4.9303, valued at
$1.2M
|
|
| 09/16/2015 |
4
| RHO VENTURES IV QP LP (10% Owner) has filed a Form 4 on IntraLinks Holdings, Inc.|
Txns:
| Sold 22,107 shares
@ $9.4862, valued at
$209.7k
Sold 11,793 shares
@ $9.3439, valued at
$110.2k
|
|
| 09/14/2015 |
4
| RHO VENTURES IV QP LP (10% Owner) has filed a Form 4 on IntraLinks Holdings, Inc.|
Txns:
| Sold 27,500 shares
@ $9.5351, valued at
$262.2k
Sold 17,333 shares
@ $9.4927, valued at
$164.5k
|
|
| 09/01/2015 |
4
| RHO VENTURES IV QP LP (10% Owner) has filed a Form 4 on IntraLinks Holdings, Inc.|
Txns:
| Sold 20,689 shares
@ $10.6412, valued at
$220.2k
Sold 57,595 shares
@ $10.3198, valued at
$594.4k
Sold 42,983 shares
@ $9.9655, valued at
$428.3k
|
|
| 06/11/2015 |
4
| LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Granted 794 shares
@ $0
Granted 4,096 options to buy
@ $69.4, valued at
$284.3k
|
|
| 02/25/2015 |
4
| RHO VENTURES IV QP LP (10% Owner) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP|
Txns:
| Converted 1,606,230 shares
@ $0
Converted 73,092 shares
@ $0
Bought 958,226 shares
@ $6, valued at
$5.7M
Converted 5,128,577 options to buy
@ $0
Converted 432,591 convertible notes
@ $0 |
|
| 01/06/2015 |
4
| Rho Ventures V, L.P. (10% Owner) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Sold 88,000 shares
@ $10.8319, valued at
$953.2k
Sold 164,919 shares
@ $10.5389, valued at
$1.7M
Sold 20,941 shares
@ $9.9011, valued at
$207.3k
|
|
| 08/29/2014 |
4
| LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Sold 13,067 shares
@ $22.5, valued at
$294k
|
|
| 06/06/2014 |
4/A
| LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Acquired 13,067 shares
@ $0 |
|
| 05/30/2014 |
4
| LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $14.22, valued at
$213.3k
|
|
| 04/03/2014 |
4
| Rho Capital Partners LLC (10% Owner) has filed a Form 4 on Everyday Health, Inc.|
Txns:
| Converted 4,554,808 shares
@ $0
Sold 92,120 shares
@ $13.02, valued at
$1.2M
Converted 1,341,057 preferred shares
@ $0
Converted 1,646,948 preferred shares
@ $0
Converted 384,874 preferred shares
@ $0
Converted 393,060 preferred shares
@ $0
Converted 1,970,210 preferred shares
@ $0
Converted 861,110 preferred shares
@ $0 |
|
| 02/19/2014 |
4
| Rho Ventures V, L.P. (10% Owner) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Converted 942,455 shares
@ $0
Converted 203,374 shares
@ $0
Granted 180,997 shares
@ $0
Converted 5,631,531 preferred shares
@ $0
Converted 494,447 preferred shares
@ $0
Converted 1,215,268 convertible notes
@ $0
Converted 106,697 convertible notes
@ $0
Converted 1,215,268 preferred shares
@ $0
Converted 106,697 preferred shares
@ $0 |
|
| 02/05/2014 |
4
| RHO Ventures VI LP (10% Owner) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Converted 2,442,239 shares
@ $0
Bought 225,818 shares
@ $11, valued at
$2.5M
Converted 6,105,598 preferred shares
@ $0 |
|
| 06/07/2013 |
4
| LESCHLY MARK (Director) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.11, valued at
$76.7k
|
|
| 05/28/2013 |
4
| RHO Ventures VI LP (10% Owner) has filed a Form 4 on BLUEFLY INC|
Txns:
| Sold 11,900,164 shares
@ $0.0076, valued at
$90.4k
Disposed of 1,875 shares
@ $0
Disposed of options to buy
@ $1500000, valued at
$0 |
|
|
|
|